MAGZEN® Effect on Recent Anxiety Reaction (STRESS2)

Laboratoire Dielen

Status: Completed

Conditions: Anxiety Disorders

Treatments: Other: Hamilton-anxiety scale (HAM-A)

Study type: Observational

Funder types: Industry

Identifiers

NCT03602651

N°ID-RCB : 2018-A01516-49

Details and patient eligibility

About

Multicentres, observational study, prospective, to evaluate the effect of MAGZEN® in the treatment of recent anxiety reaction.

Full description

107 patients suffering from recent anxiety reaction will be included in the study. They will be treated by MAGZEN® during 4 weeks and we will study the effect of this treatment on the evolution of their anxiety after the cure.

Enrollment: 110 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patient suffering from recent anxiety reaction
• Hamilton-anxiety score ≥ 20 at inclusion
• recent anxiety disorders (less than 3 months) not treated by pharmacological or psychological treatment

Exclusion criteria

• major depressive syndrome
• anxiety disorders more than 3 months
• anxiety due to death

Trial design

110 participants in 1 patient group

MAGZEN®

Description:

All patient will be treated with MAGZEN® and will be evaluated with the Hamilton-anxiety scale (HAM-A)

Treatment:

Other: Hamilton-anxiety scale (HAM-A)